| Authors: |
Eris C; Division of Immune Regulation in Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Zu C; Division of Immune Regulation in Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mainz Research School of Translational Biomedicine (TransMed), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Xiao Y; Department of Immunology, Leiden University Medical Center (LUMC), Leiden, the Netherlands., Platten M; DKTK Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.platten@dkfz.de.; Department of Neurology, MCTN, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. m.platten@dkfz.de.; DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Mannheim, Germany. m.platten@dkfz.de.; Helmholtz Institute of Translational Oncology (HI-TRON), Mainz, Germany. m.platten@dkfz.de.; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany. m.platten@dkfz.de.; SynthImmune Cluster of Excellence, Heidelberg University, Heidelberg, Germany. m.platten@dkfz.de., Sun C; Division of Immune Regulation in Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. c.sun@dkfz.de.; Helmholtz Institute of Translational Oncology (HI-TRON), Mainz, Germany. c.sun@dkfz.de.; SynthImmune Cluster of Excellence, Heidelberg University, Heidelberg, Germany. c.sun@dkfz.de.; German Cancer Consortium (DKTK), DKFZ, core center, Heidelberg, Germany. c.sun@dkfz.de. |
